Delivery Order SPE2DB22D3301-SPE2DB25FY3SA
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Abiraterone Acetate 500 mg tablets (60-count) with a ceiling value of $8,006.80. This is a firm fixed-price delivery order with an ultimate completion date of August 5, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement needs across military...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count units) valued at $1,488.86. This firm fixed-price delivery order is expected to reach completion by August 15, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting the vendor's capability to meet...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count) with a contract value of $13,351.40. The award, issued under firm fixed-price terms with no set-aside designation, represents a competitively awarded delivery order utilizing AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is located in Conshohocken,...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Abiraterone Acetate 250 mg tablets (120 count) with a ceiling value of $211,907.44. This competitively awarded, non-set-aside contract features firm fixed pricing and was executed on August 6, 2025, with an ultimate completion date of August 7, 2025. The performance location is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $10,774.15 to AmerisourceBergen Drug Corp for the supply of Abiroterone Acetate 250 mg tablets (120 count) on July 21, 2025, with completion scheduled for July 22, 2025. The contract utilizes firm fixed pricing with no set-aside designation, indicating competitive award to the pharmaceutical distributor. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, performed the work at its corporate office location....
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $3,539.30 by the Defense Logistics Agency's Medical Supply Chain on June 2, 2025, for the supply of Abiraterone Acetate 250 mg tablets (120-count). This competitively awarded, non-set-aside contract carries a firm fixed price and is scheduled for completion by June 3, 2025. The award represents a continuation of AmerisourceBergen's substantial role as a critical pharmaceutical...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Abiroterone Acetate 250 mg tablets (120-count packages) with a ceiling value of $184,749.89. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of July 22, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $104,283.60 to AmerisourceBergen Drug Corp for the supply of Abiraterone Acetate 250 mg tablets (120-count units). This competitively awarded, firm fixed-price contract was executed on August 25, 2025, with an ultimate completion date of August 26, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. No set-aside designation was applied to this award. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 120 tablets of Abiraterone Acetate 250 mg with a ceiling value of $18,846.32. This is a firm fixed-price, non-set-aside delivery order with an ultimate completion date of September 23, 2025, issued on September 22, 2025. The product will be performed and delivered from AmerisourceBergen's Conshohocken, Pennsylvania location. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order by the Defense Logistics Agency on June 17, 2025, for Abiroterone Acetate 500 mg tablets (60-count) with a ceiling value of $17,936.40. This non-set-aside, competitively awarded delivery order utilizes firm fixed pricing and carries an ultimate completion date of June 18, 2025. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY3SADelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 22, 2025, for the supply of Abiraterone Acetate 250 mg tablets in quantities of 120 units, with a ceiling value of $139,580.38. This firm fixed-price delivery order, with an ultimate completion date of April 23, 2025, represents a competitively awarded contract with no set-aside designation. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor, AmerisourceBergen serves as a critical vendor for federal medical procurement, supplying military and veteran healthcare systems with a comprehensive range of pharmaceutical products including brand-name and generic medications. The IDC vehicle enables the company to fulfill diverse pharmaceutical supply needs across multiple therapeutic domains in support of military healthcare programs worldwide, including services to the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $139.6k | 4/22/25 |